What Zap Peptides is and how it works

What this desk is

Zap Peptides is an independent editorial desk covering research on peptides studied in the context of body recomposition, lipolysis, and metabolic regulation. It is not affiliated with any pharmaceutical company, research institution, peptide vendor, or clinic. It does not sell products, run clinical trials, or provide medical advice.

The three compounds on this desk — AOD-9604, tirzepatide, and MOTS-c — were selected because they collectively illustrate a wide range of evidence maturity and regulatory status within the same metabolic theme: one with a completed but null human trial programme, one with large-scale Phase 3 RCT data and a regulatory approval, and one with compelling preclinical data but no human interventional evidence. That contrast is itself instructive for anyone evaluating the metabolic peptide literature.

Editorial method

Every claim on this desk is tied to a numbered citation in the shared references list. Citations are drawn from peer-reviewed journals, NCBI Bookshelf clinical references, and indexed conference proceedings. The desk gives preference to PubMed-indexed sources with DOIs or PMIDs.

For each compound, the desk reports:

• Study design and species first — rodent, cell, or human; RCT, observational, or mechanistic.
• Effect sizes and confidence intervals where reported in the source — not just directional claims.
• Study limitations — small samples, single-lab replication, translational gaps — stated in the same breath as the finding, not buried.
• Anecdotal community signals, where collected, are clearly labelled as anecdotal, not clinical evidence and kept separate from peer-reviewed outcomes.

The desk applies these consistency rules across all three compounds regardless of how commercially prominent or obscure any given molecule is. Tirzepatide's large RCT record is reported with the same structural template as MOTS-c's single-organism observational association — so the reader can see the difference in evidence quality directly rather than inferring it from editorial tone.

Independence and disclaimer

Zap Peptides is editorially independent. No content on this site constitutes medical advice, a diagnosis, a treatment recommendation, or an endorsement of any product, service, or vendor. No human dosing information is published anywhere on this site.

This desk is a reading resource, not a clinical service. Readers with questions about a medical condition, a prescription medication (including tirzepatide), or the safety of any research compound should consult a licensed healthcare professional. Research chemicals sold for laboratory use are not subject to pharmaceutical quality controls; their purity, identity, and safety in human use are not verified by regulatory agencies.

Links to citations point to external sources (PubMed, NCBI, publisher DOIs) that this desk does not control. Their availability may change. All reference data on this site reflects the literature as indexed at the time of compilation.